Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01SYO
|
|||
| Former ID |
DNC005004
|
|||
| Drug Name |
4-(2-Methyl-thiazol-4-ylethynyl)-pyridine
|
|||
| Synonyms |
CHEMBL303090; 4-(2-Methyl-thiazol-4-ylethynyl)-pyridine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H8N2S
|
|||
| Canonical SMILES |
CC1=NC(=CS1)C#CC2=CC=NC=C2
|
|||
| InChI |
1S/C11H8N2S/c1-9-13-11(8-14-9)3-2-10-4-6-12-7-5-10/h4-8H,1H3
|
|||
| InChIKey |
WWKCHJLBBNNNCI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist... Bioorg Med Chem Lett. 2004 Aug 2;14(15):3993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.